Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
GLP-1 Bubble Forming
Description
Deloitte warned that GLP-1 weight loss and diabetes drugs are boosting pharma R&D returns while creating concentration and bubble risk across the sector.
More from User
01:07
Gap Slashes Guidance
Benzinga
01:06
Musk Muddles SpaceX IPO
Benzinga
01:07
Waymo Hails Uber
Benzinga
01:11
Ripple CEO Praises Crypto Wins
Benzinga
01:00
BP Board Complaints
Benzinga
01:01
Tesla Leads BEV Market
Benzinga
Related Videos
02:41
Megyn Kelly Blasts Oprah Winfrey for Calling Obesity a 'Disease' as She Promotes GLP-1 Drugs During Book Tour: 'Cop Out'
Straight Arrow News
01:11
FIGHT CANCER-TAJ PHARMA Chemotherapy drugs {Taj Pharmaceutical News}
Taj Pharmaceuticals
03:09
freeworld1 pharmacy Online Pharma is a provider of treatment using drugs, specialty pharmaceuticals and other life saving drugs.
Freeworld1pharmacy123
00:20
Pharmaceutical Dissolution Testing Drugs and the Pharmaceutical Sciences Download
Loseem60
00:08
Read Pharmaceutical Particulate Carriers: Therapeutic Applications (Drugs and the Pharmaceutical
Broeks
00:05
[PDF] Modern Pharmaceutics Fourth Edition Revised and Expanded (Drugs and the Pharmaceutical
Erna Gerstner